Bioanalytical Laboratory Services

Accelerate and enhance discovery, preclinical and clinical programs.

Tailored solutions for your most complex challenges

As increasing regulatory and scientific complexities threaten R&D productivity, you need a partner with scientific competence, regulatory expertise and capacity to meet demanding timelines via tailored solutions.

Q2 Solutions offers complete bioanalytical and ADME laboratory services for testing around the globe and across the product development spectrum.  We combine knowledge from the collective services provided by our central labs, bioanalytical and ADME labs network, as well as integration into global early clinical Phase I unit. The result is timely, high-quality, regulatory compliant data that supplies the insights you need to make more informed decisions and instill confidence in your regulatory filings.

Our bioanalytical laboratory services include:

Delivery excellence

At Q2 Solutions we implement proactive quality measures and strict quality standards, proven logistics tools, and sample management and supply chain solutions delivered through our global network footprint at competitive prices with premium service.  Rigorous scientific and quality assurance reviews help to ensure the validity of reported data. Our clinical lab testing services are compliant with FDA, OECD and MHLW GLP regulations. 

Customer focus
Beyond our deep scientific expertise we understand the need for customer centric project management.  At Q2 Solutions our tailored solutions are not limited to our technical offerings but also support the overall project delivery and include customized reports, unique purchasing processes, flexible scheduling, and effective client communications, including detailed, regular project updates. Our project management teams are highly trained and committed to delivering your project on time and on budget. Each project manager is directly involved with the science and logistics of your project so they can quickly address any queries.

Shaping outcomes

Q2 Solutions not only has the technology, systems, and processes to support your routine and complex projects, but we have 20+ years of experience and industry leading knowledge to provide key insights into the development of your product.  

Q2 Solutions can help you develop methods for detecting your small and large molecule therapeutics, and to provide industry leading assays for immunogenicity assessments. The result is reliable, high-quality data for better decision-making, faster, more efficient drug development, and higher quality regulatory submissions.

Our scientific staff includes some of today’s world recognized scientific leaders that work closely with our customers to solve some of today’s bioanalytical and ADME challenges.  Our experts have published over 100 publications in the past 10 years.  Learn more about our experts and the exciting work they do to bring innovation to the drug development process.

Let’s improve human health together

Contact us  to learn more about Q2 Solutions and how we can put our tailored solutions, delivery excellence, and shaping outcomes to work for you.


Watch our webinar on-demand here to learn about the latest trends and recommendations in protein therapeutics by immunoaffinity LC-MS

Adapting and Evolving in an Era of Biologic Growth

A bioanalytical perspective

In Vitro ADME & Metabolite Identification Services List

Services to support your In Vitro ADME development needs

ADME Services

Accelerating your drug discovery, preclinical and clinical programs with ADME services

Global Flow Cytometry Services

Unique global flow cytometry services implemented with customizable solutions are designed to meet your clinical trial needs

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Quantitative Measurement of a Candidate Antibody Therapeutic in Human Plasma by LC/MS/MS using Formic Acid Digestion

Demonstration that a 2% formic acid digestion can produce a selective signature peptide for antibody quantification using nano-LC/MS/MS

Unifying Processes to Measure Entecavir in Human Matrices in Two Geographically Distinct Laboratories

Transfer of an assay between Europe and North America

Using Cyclic Nucleotides to Assess Endogenous Dilution Accuracy as a Measure of Biomarker Selectivity in LC/MS/MS

Accurate measurements of cAMP and cGMP as a useful biomarkers for development of therapeutics for a variety of indications

Strategies for effective neutralizing cell-based assays in early immunogenicity risk assessment

Read More